MarketCap
Facebook
X
Telegram
Land |
 Frankreich |
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
31 M |
Marktkapitalisierung |
$ 27.7 M |
EBITDA (LTM) |
$ -71.6 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-6.02 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
UroGen Pharma Ltd.
URGN
|
$ 34.56 | 0.08 % | $ 1.66 B | Nasdaq Global Select Market |  Israel |
 |
United Therapeutics Corporation
UTHR
|
$ 533.12 | 0.27 % | $ 23.6 B | Nasdaq Global Select Market,SPB |  USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
$ 0.21 | 0.4 % | $ 9.6 M | Nasdaq Capital Market | Israel |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
Vericel Corporation
VCEL
|
$ 40.13 | 0.33 % | $ 2.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 43.12 | 1.16 % | $ 3.39 B | Nasdaq Global Market,SPB | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.5 | 4.72 % | $ 566 M | Nasdaq Global Select Market | USA |
 |
Vir Biotechnology
VIR
|
$ 9.96 | 0.58 % | $ 1.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 25.17 | 7.46 % | $ 2.84 B | Nasdaq Capital Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 4.04 | 0.24 % | $ 238 M | Nasdaq Global Select Market,SPB | USA |
 |
Genmab A/S
GMAB
|
$ 37.0 | 0.33 % | $ 2.39 B | Nasdaq Global Select Market |  Danmark |
 |
Verrica Pharmaceuticals
VRCA
|
$ 3.6 | 0.79 % | $ 38.3 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 19.03 | 0.92 % | $ 1.94 B | Nasdaq Capital Market | USA |
 |
Inventiva S.A.
IVA
|
$ 2.94 | 8.36 % | $ 176 M | Nasdaq Global Market | France |
 |
Citius Pharmaceuticals
CTXR
|
$ 0.46 | 0.02 % | $ 5.09 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Verastem
VSTM
|
$ 8.65 | 0.05 % | $ 600 M | Nasdaq Global Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.2 | 3.1 % | $ 7.61 M | Nasdaq Global Select Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 26.54 | 0.25 % | $ 105 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 1.9 | 2.49 % | $ 112 M | Nasdaq Global Select Market | USA |
 |
Genprex
GNPX
|
$ 2.11 | 1.31 % | $ 1.97 M | Nasdaq Capital Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.13 | 0.78 % | $ 528 M | Nasdaq Global Select Market |  Singapore |
 |
Agenus
AGEN
|
$ 6.04 | 2.77 % | $ 180 M | Nasdaq Capital Market | USA |
 |
Xenetic Biosciences
XBIO
|
$ 1.98 | 0.48 % | $ 3.37 M | Nasdaq Capital Market | USA |
 |
Keros Therapeutics
KROS
|
$ 10.66 | 0.45 % | $ 397 M | Nasdaq Global Select Market | USA |
|
XBiotech
XBIT
|
$ 2.12 | 1.67 % | $ 64.6 M | Nasdaq Global Select Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 33.49 | 1.27 % | $ 2.65 B | Nasdaq Global Select Market |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 10.31 | 2.38 % | $ 1.65 B | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 2.59 | 0.19 % | $ 110 M | Nasdaq Capital Market | USA |
 |
Kodiak Sciences
KOD
|
$ 85.75 | 0.64 % | $ 4.56 B | Nasdaq Global Market,SPB | USA |
 |
22nd Century Group
XXII
|
$ 0.34 | 0.98 % | $ 62.6 K | NYSE American | USA |
 |
Halozyme Therapeutics
HALO
|
$ 121.84 | 0.27 % | $ 14.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Arvinas
ARVN
|
$ 6.97 | 1.12 % | $ 494 M | Nasdaq Global Select Market,SPB | USA |
 |
Zai Lab Limited
ZLAB
|
$ 23.19 | 0.79 % | $ 25.4 B | Nasdaq Global Select Market |  China |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 2.13 | 0.83 % | $ 153 M | Nasdaq Global Market | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.6 | 1.78 % | $ 426 M | Nasdaq Global Select Market |  Britain |
 |
BridgeBio Pharma
BBIO
|
$ 66.39 | 3.37 % | $ 12.7 B | Nasdaq Global Select Market,SPB | USA |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.21 | 4.03 % | $ 63.6 M | Nasdaq Global Select Market | USA |
 |
Harmony Biosciences Holdings
HRMY
|
$ 37.95 | 0.17 % | $ 2.18 B | Nasdaq Global Select Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 7.25 | 0.54 % | $ 111 M | Nasdaq Global Select Market |  Australia |
 |
CNS Pharmaceuticals
CNSP
|
$ 4.85 | 3.08 % | $ 2.15 M | Nasdaq Capital Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
MacroGenics
MGNX
|
$ 3.25 | 1.81 % | $ 205 M | Nasdaq Global Select Market | USA |
 |
iBio
IBIO
|
$ 0.77 | 0.63 % | $ 80.1 M | NYSE American | USA |
 |
Cytokinetics, Incorporated
CYTK
|
$ 61.95 | 0.77 % | $ 7.44 M | Nasdaq Global Select Market,SPB | USA |
 |
Immunome
IMNM
|
$ 16.47 | 1.16 % | $ 1.44 B | Nasdaq Global Select Market | USA |
 |
Immuron Limited
IMRN
|
$ 0.98 | 0.49 % | $ 226 M | Nasdaq Global Select Market | Australia |
 |
Moderna
MRNA
|
$ 218.01 | 4.51 % | $ 84.8 B | Nasdaq Global Select Market,SPB | USA |
 |
InMed Pharmaceuticals
INM
|
$ 1.32 | 0.38 % | $ 5.5 M | Nasdaq Capital Market | Canada |